rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Remus Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 45.03 24.72 18.42 11.92
Expenses
Material consumed 21.44 12.27 11.49 7.04
Manufacturing expenses - - - -
Personnel expenses 5.47 3.49 3.00 2.86
Selling expenses - - - -
Adminstrative expenses 7.57 4.89 3.17 1.63
Expenses capitalised - - - -
Cost of sales 34.48 20.65 17.66 11.53
Operating profit 10.55 4.07 0.76 0.39
Other recurring income 1.58 0.72 0.81 0.85
Adjusted PBDIT 12.12 4.79 1.57 1.24
Financial expenses 0.23 0.09 0.04 0.04
Depreciation 0.48 0.15 0.18 0.11
Other write offs - - - -
Adjusted PBT 11.41 4.55 1.36 1.09
Tax charges 2.91 1.16 0.33 0.28
Adjusted PAT 8.50 3.39 1.03 0.81
Non recurring items - - - -
Other non cash adjustments - - - -
Reported net profit 8.50 3.39 1.03 0.81
Earnigs before appropriation 14.08 6.42 3.04 2.01
Equity dividend - - - -
Preference dividend - - - -
Dividend tax - - - -
Retained earnings 14.08 6.42 3.04 2.01
Close
Add Remus Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Remus Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close